Suppression of collagen-induced arthritis by oral administration of the citrus flavonoid hesperidin

被引:62
作者
Kawaguchi, K
Maruyama, H
Kometani, T
Kumazawa, Y
机构
[1] Kitasato Univ, Sch Sci, Dept Biosci, Sagamihara, Kanagawa 2288555, Japan
[2] Kitasato Univ, Sch Pharmaceut Sci, Sagamihara, Kanagawa 228, Japan
[3] Kitasato Univ, Sch Allied Hlth Sci, Dept Pathol, Sagamihara, Kanagawa 228, Japan
[4] Ezaki Glico Co Ltd, Cent Res Lab, Osaka, Japan
[5] Kitasato Univ, Grad Sch Fundamental Life Sci, Sagamihara, Kanagawa 228, Japan
关键词
D O I
10.1055/s-2005-916254
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
The preventive and therapeutic effects of the Citrus flavonoid hesperidin (HES) on the development of collagen-induced arthritis (CIA), a mouse model of rheumatoid arthritis (RA), were investigated. Mice were administered orally HES three times a week starting from either the onset (day 21) of secondary immunization or on day 31, when the CIA development had reached a plateau. In both cases, treatment with HES resulted in a significant suppression of clinical scores and improvement of histological features. These results suggest that oral administration of HES could be effective for treating human RA patients.
引用
收藏
页码:477 / 479
页数:3
相关论文
共 12 条
[1]
BRAHN E, 1992, LYMPHOKINE CYTOK RES, V11, P253
[2]
LOCALIZATION OF TUMOR-NECROSIS-FACTOR-ALPHA IN SYNOVIAL TISSUES AND AT THE CARTILAGE PANNUS JUNCTION IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
CHU, CQ ;
FIELD, M ;
FELDMANN, M ;
MAINI, RN .
ARTHRITIS AND RHEUMATISM, 1991, 34 (09) :1125-1132
[3]
MEDIATORS OF JOINT SWELLING AND DAMAGE IN RHEUMATOID-ARTHRITIS AND PRISTANE INDUCED ARTHRITIS [J].
ELSON, CJ ;
THOMPSON, SJ ;
WESTACOTT, CI ;
BHOOLA, KD .
AUTOIMMUNITY, 1992, 13 (04) :327-331
[4]
CYTOKINE ASSAYS - ROLE IN EVALUATION OF THE PATHOGENESIS OF AUTOIMMUNITY [J].
FELDMANN, M ;
BRENNAN, FM ;
CHANTRY, D ;
HAWORTH, C ;
TURNER, M ;
KATSIKIS, P ;
LONDEI, M ;
ABNEY, E ;
BUCHAN, G ;
BARRETT, K ;
CORCORAN, A ;
KISSONERGHIS, M ;
ZHENG, R ;
GRUBECKLOEBENSTEIN, B ;
BARKLEY, D ;
CHU, CQ ;
FIELD, M ;
MAINI, RN .
IMMUNOLOGICAL REVIEWS, 1991, 119 :105-123
[5]
Anti-TNFα therapy of rheumatoid arthritis:: what have we learned? [J].
Feldmann, M ;
Maini, RN .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :163-196
[6]
One-year inhibition of tumor necrosis factor-α:: a major success or a larger puzzle? [J].
Graninger, WB ;
Smolen, JS .
CURRENT OPINION IN RHEUMATOLOGY, 2001, 13 (03) :209-213
[7]
A citrus flavonoid hesperidin suppresses infection-induced endotoxin shock in mice [J].
Kawaguchi, K ;
Kikuchi, S ;
Hasunuma, R ;
Maruyama, H ;
Yoshikawa, T ;
Kumazawa, Y .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (05) :679-683
[8]
Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin [J].
Kawaguchi, K ;
Kikuchi, S ;
Hasegawa, H ;
Maruyama, H ;
Morita, H ;
Kumazawa, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 368 (2-3) :245-250
[9]
Rheumatoid arthritis and its animal models:: the role of TNF-α and the possible absence of specific immune reactions [J].
Klareskog, L ;
McDevitt, H .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (06) :657-662
[10]
Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis. [J].
Ted R. Mikuls ;
Arthur L. Weaver .
Current Rheumatology Reports, 2003, 5 (4) :270-277